Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisoprolol crossover study in adults with asthma
ACTRN12618000306213Phase 4Completed
- Sponsor
- Waikato District Health Board
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of bisoprolol and salbutamol in asthma (3 arms), sponsored by Waikato District Health Board. Primary endpoint: Area under the FEV1 recovery curve after salbutamol. Started Jul 2018; status: completed.
02
Drugs
bisoprololsalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on ACTRN12618000306213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000306213.